| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 8 |
| 1 | DOCETAXEL | 7 |
| 2 | DOCETAXEL ANHYDROUS | 7 |
| 3 | METHOTREXATE | 7 |
| 4 | PERTUZUMAB | 7 |
| 5 | PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF | 7 |
| 6 | TRASTUZUMAB | 7 |
| 7 | EFAVIRENZ | 5 |
| 8 | LAMIVUDINE | 5 |
| 9 | LAMIVUDINE ORAL | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF | 7 | 0.0014 |
| 1 | CYCLOSERINE | 3 | 0.0013 |
| 2 | COLISTIMETHATE SODIUM | 1 | 0.0006 |
| 3 | ZIDOVUDINE | 5 | 0.0005 |
| 4 | GRANULOCYTE COLONY STIMULATING FACTOR | 1 | 0.0005 |
| 5 | EFAVIRENZ | 5 | 0.0005 |
| 6 | PYRIDOXINE HYDROCHLORIDE | 1 | 0.0004 |
| 7 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 3 | 0.0003 |
| 8 | CROMOLYN SODIUM | 1 | 0.0003 |
| 9 | PERTUZUMAB | 7 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 7 | 0.0038 |
| 1 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 2 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0002 |
| 3 | Interleukin-17A Antagonist [EPC] | 5 | 0.0001 |
| 4 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0001 |
| 5 | Oxazolidinone Antibacterial [EPC] | 3 | 0.0001 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 7 | 0.0001 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 8 | Aminoglycoside Antibacterial [EPC] | 3 | 0.0001 |
| 9 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |